Menu
GeneBe

rs587783404

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001323289.2(CDKL5):c.283-13A>G variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000249 in 1,202,435 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 11 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★★).

Frequency

Genomes: 𝑓 0.000098 ( 0 hom., 5 hem., cov: 23)
Exomes 𝑓: 0.000017 ( 0 hom. 6 hem. )

Consequence

CDKL5
NM_001323289.2 splice_polypyrimidine_tract, intron

Scores

2

Clinical Significance

Benign reviewed by expert panel U:1B:3

Conservation

PhyloP100: -0.259
Variant links:
Genes affected
CDKL5 (HGNC:11411): (cyclin dependent kinase like 5) This gene is a member of Ser/Thr protein kinase family and encodes a phosphorylated protein with protein kinase activity. Mutations in this gene have been associated with X-linked infantile spasm syndrome (ISSX), also known as X-linked West syndrome, and Rett syndrome (RTT). Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant X-18579835-A-G is Benign according to our data. Variant chrX-18579835-A-G is described in ClinVar as [Benign]. Clinvar id is 158184.Status of the report is reviewed_by_expert_panel, 3 stars.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.0000985 (11/111705) while in subpopulation AMR AF= 0.000478 (5/10456). AF 95% confidence interval is 0.000188. There are 0 homozygotes in gnomad4. There are 5 alleles in male gnomad4 subpopulation. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd at 5 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CDKL5NM_001323289.2 linkuse as main transcriptc.283-13A>G splice_polypyrimidine_tract_variant, intron_variant ENST00000623535.2
CDKL5NM_001037343.2 linkuse as main transcriptc.283-13A>G splice_polypyrimidine_tract_variant, intron_variant
CDKL5NM_003159.3 linkuse as main transcriptc.283-13A>G splice_polypyrimidine_tract_variant, intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CDKL5ENST00000623535.2 linkuse as main transcriptc.283-13A>G splice_polypyrimidine_tract_variant, intron_variant 1 NM_001323289.2 P1O76039-2

Frequencies

GnomAD3 genomes
AF:
0.0000985
AC:
11
AN:
111705
Hom.:
0
Cov.:
23
AF XY:
0.000148
AC XY:
5
AN XY:
33897
show subpopulations
Gnomad AFR
AF:
0.0000649
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000478
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000377
Gnomad OTH
AF:
0.00133
GnomAD3 exomes
AF:
0.0000712
AC:
13
AN:
182610
Hom.:
0
AF XY:
0.0000742
AC XY:
5
AN XY:
67352
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000330
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000368
Gnomad OTH exome
AF:
0.000223
GnomAD4 exome
AF:
0.0000174
AC:
19
AN:
1090730
Hom.:
0
Cov.:
27
AF XY:
0.0000168
AC XY:
6
AN XY:
357214
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000256
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000186
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000598
Gnomad4 OTH exome
AF:
0.0000873
GnomAD4 genome
AF:
0.0000985
AC:
11
AN:
111705
Hom.:
0
Cov.:
23
AF XY:
0.000148
AC XY:
5
AN XY:
33897
show subpopulations
Gnomad4 AFR
AF:
0.0000649
Gnomad4 AMR
AF:
0.000478
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000377
Gnomad4 OTH
AF:
0.00133
Alfa
AF:
0.000214
Hom.:
1
Bravo
AF:
0.000215

ClinVar

Significance: Benign
Submissions summary: Uncertain:1Benign:3
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

Developmental and epileptic encephalopathy, 2 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoJun 10, 2013- -
CDKL5 disorder Benign:1
Benign, reviewed by expert panelcurationClinGen Rett and Angelman-like Disorders Variant Curation Expert PanelApr 14, 2023The allele frequency of the c.283-13 A>G variant in CDKL5 is 0.036% in Latino sub population in gnomAD, which is high enough to be classified as benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BA1). In summary, the c.283-13 A>G variant in CDKL5 is classified as benign based on the ACMG/AMP criteria (BA1). -
not provided Benign:1
Likely benign, criteria provided, single submitterclinical testingGeneDxMay 05, 2021- -
Developmental and epileptic encephalopathy, 2;CN128785:Angelman syndrome-like Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeJan 12, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
Cadd
Benign
0.16
Dann
Benign
0.72

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs587783404; hg19: chrX-18597955; API